Search results
Jump to navigation
Jump to search
Page title matches
- '''Genetic polymorphism''' is the "regular and simultaneous occurrence in a single interbreeding po431 bytes (53 words) - 02:26, 7 October 2013
- 179 bytes (24 words) - 10:13, 5 September 2009
- 12 bytes (1 word) - 23:07, 3 February 2008
- Auto-populated based on [[Special:WhatLinksHere/Genetic polymorphism]]. Needs checking by a human.616 bytes (75 words) - 16:49, 11 January 2010
Page text matches
- {{r|Genetic polymorphism}}148 bytes (15 words) - 11:38, 31 May 2009
- '''Genetic polymorphism''' is the "regular and simultaneous occurrence in a single interbreeding po431 bytes (53 words) - 02:26, 7 October 2013
- Auto-populated based on [[Special:WhatLinksHere/Genetic polymorphism]]. Needs checking by a human.616 bytes (75 words) - 16:49, 11 January 2010
- {{r|Genetic polymorphism}}237 bytes (27 words) - 01:00, 9 February 2010
- {{r|Genetic polymorphism}}775 bytes (100 words) - 19:42, 11 January 2010
- {{r|Genetic polymorphism}}641 bytes (79 words) - 16:44, 11 January 2010
- {{r|Genetic polymorphism}}926 bytes (114 words) - 15:48, 11 January 2010
- G protein–coupled [[cell surface receptor]] kinase 2 (GRK2) [[genetic polymorphism]]s may also affect the response to [[adrenergic beta-antagonist]]s.<ref>{{O [[Genetic polymorphism]]s may affect the response to [[adrenergic beta-antagonist]]s by patients o5 KB (679 words) - 09:15, 29 August 2009
- [[Genetic polymorphism]]s of beta-1 (ADRB1) may affect the response to [[adrenergic beta-antagonis [[Genetic polymorphism]]s of alpha-2C (ADRA2C) may affect the response to [[adrenergic beta-antago6 KB (767 words) - 17:34, 10 February 2024
- Testing for Hardy–Weinberg equilibrium is studies of associations between [[genetic polymorphism]]s and diseases is controversial.<ref name="pmid17044866">{{cite journal| a3 KB (362 words) - 08:44, 13 August 2010
- ...'single-nucleotide polymorphism''' ('''SNP''', pronounced ''snip'') is a [[genetic polymorphism]] in which a [[DNA sequence]] variation is a single [[nucleotide]] —7 KB (957 words) - 10:47, 30 March 2010
- [[Genetic polymorphism]]s of the beta-1 receptor may affect responses to [[adrenergic beta-antagon [[Genetic polymorphism]]s of alpha-2C (ADRA2C) may affect the response to adrenergic beta-antagoni12 KB (1,491 words) - 23:11, 12 October 2011
- ...in animals of the breed who exhibit the trait, or the gene haplotype or a genetic polymorphism is found in the breed and indicates the ancestry of the breed. For example,15 KB (2,394 words) - 12:02, 18 May 2023
- [[Genetic polymorphism|Polymorphisms]] of CYP2C9 explain 10% of variation in [[warfarin]] dosing<r22 KB (2,960 words) - 17:35, 10 February 2024
- G protein–coupled [[cell surface receptor]] kinase 2 (GRK2) [[genetic polymorphism]]s may also affect the response to [[adrenergic beta-antagonist]]s.<ref>{{O [[Genetic polymorphism]]s of beta-1 (ADRB1) may affect the response to adrenergic beta-antagonist36 KB (4,786 words) - 23:10, 12 October 2011
- ...ery P, Monkhouse L, King BP et al.| title=The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for [[Genetic polymorphism]]s in the ''[[vitamin K epoxide reductase]] complex 1 (VKORC1)'' gene expla52 KB (7,136 words) - 22:53, 6 April 2014
- ...ug toxicity]] among patients with abnormal beta1-[[adrenergic receptor]] [[genetic polymorphism]]s.<ref name="pmid17585213"/>21 KB (2,642 words) - 17:32, 10 February 2024
- ...ions are eliminated along with the deleterious variant, resulting in lower genetic polymorphism in the surrounding region.53 KB (7,846 words) - 16:55, 24 May 2012
- * [[Genetic polymorphism]]25 KB (3,396 words) - 13:29, 2 April 2024